Xenleta (lefamulin oral) / Sumitomo Pharma, Nabriva Therap  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xenleta (lefamulin oral) / Nabriva Therap, Sumitomo Pharma
LEAP, NCT02559310 / 2014-005169-63: Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

Completed
3
551
Europe, US, RoW
lefamulin, BC-3781, Moxifloxacin, Avelox, Linezolid, Zyvox
Nabriva Therapeutics AG
Community Acquired Pneumonia
04/17
05/17
LEAP2, NCT02813694 / 2015-004782-92: Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia

Completed
3
738
Europe, US, RoW
lefamulin, BC-3781, Moxifloxacin, Avelox
Nabriva Therapeutics AG
Community Acquired Pneumonia
01/18
01/18

Download Options